Aegis Capital Corporation v. Cocrystal Pharma, Inc.
| Aegis Capital Corp. and Aegis Capital Corporation |
| Cocrystal Pharma, Inc. |
| 1:2020cv01986 |
| March 5, 2020 |
| US District Court for the Southern District of New York |
| John G Koeltl |
| Contract: Other |
| 28 U.S.C. ยง 1332 bc |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 12, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 STIPULATION OF VOLUNTARY DISMISSAL It is hereby stipulated and agreed by and between the parties and/or their respective counsel(s) that the above-captioned action is voluntarily dismissed, with prejudice against the defendant(s) Cocrystal Pharma, Inc. and without costs pursuant to Rule 41(a)(1)(A)(ii) of the Federal Rules of Civil Procedure. Document filed by Aegis Capital Corporation. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Whalen, Ryan) |
Filing 9
ORDER OF DISCONTINUANCE: It having been reported to this Court that the parties have settled this action, It is, on this 10th day of March, 2020, hereby ordered that this matter be discontinued with prejudice but without costs; provided, however, that within 30 days of the date of this order, counsel for the plaintiff may apply by letter for restoration of the action to the calendar of the undersigned, in which event the action will be restored. Any application to reopen must be filed within thirty (30) days of this order; any application to reopen filed thereafter may be denied solely on that basis. Further, if the parties wish for the Court to retain jurisdiction for the purpose of enforcing any settlement agreement, they must submit the settlement agreement to the Court within the same thirty-day period to be "so ordered" by the Court. Unless the Court orders otherwise, the Court will not retain jurisdiction to enforce a settlement agreement unless it is made part of the public record. All pending motions are dismissed as moot. All conferences are canceled. The Clerk of Court is directed to close this case. SO ORDERED. (Signed by Judge John G. Koeltl on 3/10/2020) (ks)
|
| Filing 8 NOTICE OF APPEARANCE by Steven J. Shore on behalf of Cocrystal Pharma, Inc...(Shore, Steven) |
| Filing 7 NOTICE OF APPEARANCE by Dawn M. Wilson on behalf of Cocrystal Pharma, Inc...(Wilson, Dawn) |
| Filing 6 ELECTRONIC SUMMONS ISSUED as to Cocrystal Pharma, Inc...(pne) |
| ***NOTICE TO ATTORNEY REGARDING PARTY MODIFICATION. Notice to attorney Ryan James Whalen. The party information for the following party/parties has been modified: Aegis Capital Corporation. The information for the party/parties has been modified for the following reason/reasons: party name contained a typographical error. (pne) |
| ***NOTICE TO ATTORNEY REGARDING CIVIL CASE OPENING STATISTICAL ERROR CORRECTION: Notice to attorney Ryan James Whalen. The following case opening statistical information was erroneously selected/entered: Nature of Suit code 150 (Contract: Recovery/Enforcement). The following correction(s) have been made to your case entry: the Nature of Suit code has been modified to 190 (Contract: Other). (pne) |
| Case Designated ECF. (pne) |
| Magistrate Judge Sarah Netburn is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pne) |
| CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge John G. Koeltl. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(pne) |
| Filing 5 NOTICE OF APPEARANCE by Kari Parks on behalf of Aegis Capital Corp...(Parks, Kari) |
| Filing 4 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Aegis Capital Corp...(Whalen, Ryan) |
| Filing 3 CIVIL COVER SHEET filed..(Whalen, Ryan) |
| Filing 2 REQUEST FOR ISSUANCE OF SUMMONS as to Cocrystal Pharma, Inc., re: #1 Complaint,. Document filed by Aegis Capital Corp...(Whalen, Ryan) |
| Filing 1 COMPLAINT against Cocrystal Pharma, Inc.. (Filing Fee $ 400.00, Receipt Number ANYSDC-19022782)Document filed by Aegis Capital Corp.. (Attachments: #1 Exhibit U/W Agreement, #2 Exhibit January 2020 Consent Waiver, #3 Exhibit February 27, 2020 Press Release, #4 Exhibit February 28, 2020 Press Release).(Whalen, Ryan) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
